Alicja Sundblade
Family · Charlotte, NCNPI 1184059958
Payments from drug & device makers
Across 120 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$342
- Lilly USA, LLC$232
- AbbVie$216
- Pfizer$215
- Boehringer Ingelheim$196
- Amgen$121
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,355100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $342 |
| Lilly USA, LLC | 13 | $232 |
| AbbVie | 11 | $216 |
| Pfizer | 10 | $215 |
| Boehringer Ingelheim | 9 | $196 |
| Amgen | 7 | $121 |
| AstraZeneca | 7 | $114 |
| Exact Sciences | 5 | $100 |
| Bayer | 5 | $87 |
| Astellas Pharma US Inc | 3 | $71 |
| Abbott | 3 | $68 |
| Shield Therapeutics Inc | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Globus Medical | 1 | $40 |
| Merck | 2 | $39 |
| Medtronic | 2 | $36 |
| GSK | 2 | $35 |
| Johnson & Johnson | 2 | $34 |
| Boston Scientific | 1 | $25 |
| Nevro Corp. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Atland Pharmaceuticals, LLC | 1 | $14 |
How this compares
$2,355 in reported general payments places this provider in the 85th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 25 | $384 |
| Duloxetine Hcl | 19 | $349 |
| Levothyroxine Sodium | 23 | $214 |
| Famotidine | 15 | $213 |
| Fluticasone Propionate | 21 | $210 |
| Metformin Hcl ErMetformin Hcl | 18 | $187 |
| Atorvastatin Calcium | 29 | $184 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $132 |
| Bupropion XlBupropion Hcl | 14 | $123 |
| Rosuvastatin Calcium | 17 | $77 |
| Potassium Chloride | 11 | $77 |
| Losartan Potassium | 18 | $73 |
| Sertraline Hcl | 11 | $48 |
| Trazodone Hcl | 11 | $39 |
| Amlodipine Besylate | 23 | $33 |
Paid to pharmacies, not to this prescriber.
Other family in Charlotte
- Debra ScottCharlotte$129K
- Lasherri LeathersCharlotte$89K
- Catherine ShahCharlotte$72K
- Jason HardinCharlotte$37K
- Laura ListonCharlotte$33K
- Marie KristensenCharlotte$30K
- Hadley DebergCharlotte$16K
- Morgan HubeliCharlotte$15K
- Trisha WootenCharlotte$15K
- Samantha GriffinCharlotte$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.